Put companies on watchlist
AEVIS VICTORIA SA
ISIN: CH0478634105
WKN: A2PLW7
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

AEVIS VICTORIA SA · ISIN: CH0478634105 · EQS - adhoc news (67 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 1338829
28 April 2022 05:40PM

all proposals approved


AEVIS VICTORIA SA / Key word(s): AGMEGM
AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved

28-Apr-2022 / 17:40 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 28 April 2022

AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved

AEVIS VICTORIA SA (AEVIS) today held its Ordinary General Meeting for the financial year 2021. All the agenda items were approved. The 2021 annual accounts were accepted and discharge was granted to the Board Members and to the Management. The existing Board Members, namely Christian Wenger (Chairman), Raymond Loretan (Vice-Chairman), Antoine Hubert (Delegate of the Board), Michel Reybier, Antoine Kohler and Dr Cédric A. George were re-elected for a one-year term until the end of the next Ordinary General Meeting. Dr Cédric A. George and Antoine Kohler were re-elected respectively as Chairman and Member of the Nomination and Remuneration Committee.

The shareholders approved the appropriation of retained earnings including an allocation to the legal retained earnings of CHF 475'685, an ordinary distribution of CHF 0.40 per share and an extraordinary distribution of CHF 0.60 per share. The ordinary dividend distribution of CHF 0.20 per share (CHF 0.13 net) and the ordinary distribution from capital contribution reserves of CHF 0.20 per share will be paid on 4 May 2022 (ex-date 2 May 2022). The extraordinary dividend distribution of CHF 0.30 per share (CHF 0.195 net) and the extraordinary distribution from capital contribution reserves of CHF 0.30 per share will be paid on 5 July 2022 (ex-date 1 July 2022).

The shareholders also approved the amendments to the Articles of Association in connection with the Swiss Corporate Law Reform, in particular on the holding of general meetings, and the increase and extension of the authorized capital.

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren, svanderschueren@aevis.com, +41 (0) 79 635 04 10

AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network SA (90%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, Victoria-Jungfrau AG, a luxury hotel group managing ten luxury hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.


Additional features:


File: AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved

End of ad hoc announcement

1338829  28-Apr-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1338829&application_name=news&site_id=boersengefluester_html
Visual performance / price development - AEVIS VICTORIA SA
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.